Compound 3q6 is a potent small molecule agent effective against methicillin-resistant Staphylococcus aureus (MRSA). It demonstrates low cytotoxicity in human cell lines such as MCF-7 and A549, making it a promising candidate for in vitro antibacterial research and the development of novel anti-infective therapeutics.